Derek Archila
Stock Analyst at Wells Fargo
(4.28)
# 415
Out of 5,124 analysts
212
Total ratings
53.85%
Success rate
14.68%
Average return
Main Sectors:
Stocks Rated by Derek Archila
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintains: Overweight | $1,316 → $1,264 | $801.18 | +57.77% | 14 | Dec 16, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Overweight | $21 → $30 | $17.20 | +74.42% | 7 | Dec 16, 2025 | |
| KYTX Kyverna Therapeutics | Maintains: Overweight | $31 → $33 | $7.85 | +320.38% | 4 | Dec 16, 2025 | |
| IRON Disc Medicine | Maintains: Overweight | $91 → $109 | $76.47 | +42.54% | 1 | Dec 16, 2025 | |
| GLUE Monte Rosa Therapeutics | Upgrades: Overweight | $13 → $22 | $13.96 | +57.59% | 8 | Dec 16, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Overweight | $69 → $116 | $73.05 | +58.80% | 10 | Dec 9, 2025 | |
| ORIC ORIC Pharmaceuticals | Maintains: Overweight | $19 → $25 | $8.09 | +209.21% | 2 | Dec 8, 2025 | |
| INCY Incyte | Maintains: Overweight | $97 → $116 | $107.27 | +8.14% | 11 | Dec 8, 2025 | |
| ANNX Annexon | Maintains: Overweight | $14 → $27 | $5.07 | +433.07% | 4 | Nov 19, 2025 | |
| SEPN Septerna | Upgrades: Overweight | $18 → $28 | $25.45 | +10.02% | 5 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $76 → $84 | $72.72 | +15.51% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $395 → $479 | $403.94 | +18.58% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $11 → $14 | $7.47 | +87.42% | 5 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $15 | $11.70 | +28.26% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $123 → $106 | $45.64 | +132.28% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $81 | $43.71 | +85.31% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $36 → $30 | $43.73 | -31.40% | 4 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $6.26 | -20.13% | 12 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $29 → $32 | $23.75 | +34.74% | 13 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $10 | $2.06 | +385.44% | 6 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $25 → $1 | $0.72 | +39.24% | 3 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $44 → $38 | $26.20 | +45.04% | 4 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $40 → $30 | $11.10 | +170.27% | 1 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $3 → $2 | $2.06 | -2.91% | 11 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $289 → $295 | $209.29 | +40.95% | 14 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $1.84 | +172.48% | 5 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $27 → $26 | $30.75 | -15.43% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $17 | $16.50 | +3.03% | 1 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $91 → $129 | $99.00 | +30.30% | 6 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $15 | $3.40 | +341.83% | 2 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $14 | $23.85 | -41.30% | 5 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $45 | $25.60 | +75.78% | 9 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $37 → $20 | $3.72 | +438.36% | 7 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $4.56 | +294.74% | 1 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $298 → $193 | $32.54 | +493.21% | 1 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $61 → $41 | $71.45 | -42.62% | 1 | Apr 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $480 → $160 | $13.56 | +1,079.94% | 3 | Mar 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $180 → $60 | $17.00 | +252.94% | 3 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | $29 | $8.13 | +256.70% | 4 | Dec 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $34 → $50 | $1.24 | +3,948.58% | 2 | Jun 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $51 | $21.83 | +133.62% | 1 | Nov 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $88 | $14.65 | +500.89% | 1 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $25.14 | - | 1 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $32.03 | - | 2 | Aug 3, 2017 |
argenx SE
Dec 16, 2025
Maintains: Overweight
Price Target: $1,316 → $1,264
Current: $801.18
Upside: +57.77%
Nurix Therapeutics
Dec 16, 2025
Maintains: Overweight
Price Target: $21 → $30
Current: $17.20
Upside: +74.42%
Kyverna Therapeutics
Dec 16, 2025
Maintains: Overweight
Price Target: $31 → $33
Current: $7.85
Upside: +320.38%
Disc Medicine
Dec 16, 2025
Maintains: Overweight
Price Target: $91 → $109
Current: $76.47
Upside: +42.54%
Monte Rosa Therapeutics
Dec 16, 2025
Upgrades: Overweight
Price Target: $13 → $22
Current: $13.96
Upside: +57.59%
Kymera Therapeutics
Dec 9, 2025
Maintains: Overweight
Price Target: $69 → $116
Current: $73.05
Upside: +58.80%
ORIC Pharmaceuticals
Dec 8, 2025
Maintains: Overweight
Price Target: $19 → $25
Current: $8.09
Upside: +209.21%
Incyte
Dec 8, 2025
Maintains: Overweight
Price Target: $97 → $116
Current: $107.27
Upside: +8.14%
Annexon
Nov 19, 2025
Maintains: Overweight
Price Target: $14 → $27
Current: $5.07
Upside: +433.07%
Septerna
Nov 14, 2025
Upgrades: Overweight
Price Target: $18 → $28
Current: $25.45
Upside: +10.02%
Nov 11, 2025
Maintains: Overweight
Price Target: $76 → $84
Current: $72.72
Upside: +15.51%
Nov 11, 2025
Maintains: Equal-Weight
Price Target: $395 → $479
Current: $403.94
Upside: +18.58%
Nov 7, 2025
Maintains: Overweight
Price Target: $11 → $14
Current: $7.47
Upside: +87.42%
Nov 6, 2025
Maintains: Overweight
Price Target: $16 → $15
Current: $11.70
Upside: +28.26%
Nov 5, 2025
Maintains: Overweight
Price Target: $123 → $106
Current: $45.64
Upside: +132.28%
Nov 5, 2025
Maintains: Overweight
Price Target: $51 → $81
Current: $43.71
Upside: +85.31%
Oct 21, 2025
Maintains: Equal-Weight
Price Target: $36 → $30
Current: $43.73
Upside: -31.40%
Oct 17, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $6.26
Upside: -20.13%
Oct 15, 2025
Upgrades: Overweight
Price Target: $29 → $32
Current: $23.75
Upside: +34.74%
Sep 23, 2025
Maintains: Overweight
Price Target: $5 → $10
Current: $2.06
Upside: +385.44%
Sep 16, 2025
Downgrades: Equal-Weight
Price Target: $25 → $1
Current: $0.72
Upside: +39.24%
Aug 20, 2025
Maintains: Overweight
Price Target: $44 → $38
Current: $26.20
Upside: +45.04%
Aug 12, 2025
Maintains: Equal-Weight
Price Target: $40 → $30
Current: $11.10
Upside: +170.27%
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $3 → $2
Current: $2.06
Upside: -2.91%
Aug 8, 2025
Maintains: Overweight
Price Target: $289 → $295
Current: $209.29
Upside: +40.95%
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $1.84
Upside: +172.48%
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $27 → $26
Current: $30.75
Upside: -15.43%
Jul 25, 2025
Initiates: Overweight
Price Target: $17
Current: $16.50
Upside: +3.03%
Jul 10, 2025
Maintains: Overweight
Price Target: $91 → $129
Current: $99.00
Upside: +30.30%
Mar 12, 2025
Maintains: Equal-Weight
Price Target: $16 → $15
Current: $3.40
Upside: +341.83%
Dec 19, 2024
Maintains: Equal-Weight
Price Target: $12 → $14
Current: $23.85
Upside: -41.30%
Dec 19, 2024
Maintains: Overweight
Price Target: $47 → $45
Current: $25.60
Upside: +75.78%
May 5, 2021
Downgrades: Hold
Price Target: $37 → $20
Current: $3.72
Upside: +438.36%
Aug 4, 2020
Initiates: Buy
Price Target: $18
Current: $4.56
Upside: +294.74%
Jul 10, 2020
Downgrades: Hold
Price Target: $298 → $193
Current: $32.54
Upside: +493.21%
Apr 15, 2020
Reiterates: Buy
Price Target: $61 → $41
Current: $71.45
Upside: -42.62%
Mar 31, 2020
Maintains: Hold
Price Target: $480 → $160
Current: $13.56
Upside: +1,079.94%
Mar 17, 2020
Downgrades: Hold
Price Target: $180 → $60
Current: $17.00
Upside: +252.94%
Dec 11, 2018
Downgrades: Perform
Price Target: $29
Current: $8.13
Upside: +256.70%
Jun 22, 2018
Maintains: Outperform
Price Target: $34 → $50
Current: $1.24
Upside: +3,948.58%
Nov 15, 2017
Maintains: Outperform
Price Target: $32 → $51
Current: $21.83
Upside: +133.62%
Sep 7, 2017
Initiates: Outperform
Price Target: $88
Current: $14.65
Upside: +500.89%
Sep 7, 2017
Initiates: Market Perform
Price Target: n/a
Current: $25.14
Upside: -
Aug 3, 2017
Downgrades: Perform
Price Target: n/a
Current: $32.03
Upside: -